STOCK TITAN

Ventas, Inc. Form 4 Filings

VTR NYSE

Every Form 4 that Ventas, Inc. (VTR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow VTR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VTR filings page.

Rhea-AI Summary

Ventas, Inc. director Sumit Roy reported automatic acquisitions of common stock units linked to dividends. On January 15, 2026, he received 48.195 common stock units under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan and 68.063 units under the Non-Employee Directors' Equity Award Deferral Program, both credited as dividend equivalents on Ventas' common stock. Each grant used a reference price of $76.92 per share. After these transactions, Roy directly beneficially owned 21,859.714 shares of Ventas common stock in total.

Rhea-AI Summary

Ventas, Inc. director Joe Vasquez Rodriguez Jr. reported an automatic grant linked to dividends rather than an open-market trade. On January 15, 2026, he acquired 42.037 units of common stock under the Ventas Non-Employee Directors' Equity Award Deferral Program, tied to dividend equivalents on the company’s common stock. The filing notes a reference price of $76.92 per share, which reflects the closing price on the grant date. After this transaction, Rodriguez beneficially owns 7,806.498 shares of Ventas common stock in direct form. The units are payable solely in common stock and remain subject to his deferral election and the terms of the program.

Rhea-AI Summary

Ventas, Inc. director Marguerite M. Nader reported an automatic acquisition of common stock units under the company’s Non-Employee Directors' Equity Award Deferral Program. On January 15, 2026, she received 68.063 common stock units at a value based on the $76.92 closing price of Ventas common stock on the grant date, reflecting dividend equivalents on the company’s common stock dividend paid that day.

After this transaction, Nader beneficially owned 21,358.216 shares of Ventas common stock in direct form. The units are payable solely in common stock and remain subject to the terms of her deferral election and the Program, which was adopted under the Ventas, Inc. 2022 Incentive Plan.

Rhea-AI Summary

Ventas, Inc. director Matthew J. Lustig reported routine share accruals tied to board compensation programs. On January 15, 2026, he acquired 231.163 shares of Ventas common stock at $76.92 per share through units granted under the company’s Non-Employee Directors' Cash Compensation Deferral Plan as dividend equivalents on the common stock dividend paid that day.

On the same date, he acquired an additional 68.063 shares at $76.92 per share through units credited under the Non-Employee Directors' Equity Award Deferral Program, also as dividend equivalents on the January 15 dividend. After these transactions, Lustig directly beneficially owned 92,266.446 shares of Ventas common stock, with all units payable solely in stock under the terms of his deferral elections and the applicable plans.

Rhea-AI Summary

Ventas, Inc. director Roxanne M. Martino acquired 187.938 common stock units on January 15, 2026 through the company’s Non-Employee Directors' Cash Compensation Deferral Plan. These units were credited as dividend equivalents tied to a cash dividend paid on that date and are payable solely in common stock under the terms of her deferral election and the plan. The filing reports a reference closing price of $76.92 per share as of the grant date, and shows that she beneficially owned a total of 63,267.777 shares of common stock in direct ownership following this transaction.

Rhea-AI Summary

Ventas, Inc. director Michael J. Embler reported a small stock-based award related to his board service. On January 15, 2026, he acquired 68.063 shares of common stock at a reference price of $76.92 per share. The award came as units under Ventas' Non-Employee Directors' Equity Award Deferral Program, credited as dividend equivalents on the company’s common stock and payable solely in shares. After this grant, Embler directly beneficially owned 14,588.216 shares of Ventas common stock.

Rhea-AI Summary

Ventas, Inc. director Melody C. Barnes reported a small stock unit accrual under a director equity program. On January 15, 2026, she acquired 68.063 units of common stock, coded as an acquisition, at a reference price of $76.92 per share, which reflects the closing market price on the grant date. The units were credited as dividend equivalents under the Ventas Non-Employee Directors' Equity Award Deferral Program adopted pursuant to the 2022 Incentive Plan and are payable solely in common stock. Following this transaction, she directly beneficially owned 33,193.216 shares of Ventas common stock in total.

Rhea-AI Summary

Ventas, Inc. director reports acquisition of deferred stock units

A Ventas, Inc. director reported receiving 484.935 common shares on 01/02/2026 under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. These units were granted in lieu of cash director fees, based on a closing share price of $77.33 on the grant date and are payable solely in common stock under the terms of the director’s deferral election and the plan. Following this transaction, the director beneficially owned a total of 27,966.806 shares of Ventas common stock in direct ownership.

Rhea-AI Summary

Ventas, Inc. director reports routine equity compensation. A director of Ventas, Inc. (VTR) reported receiving 404.112 shares of common stock, in the form of stock units granted under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. These units were issued on 01/02/2026 in lieu of cash director fees, at a value based on the $77.33 closing price of Ventas common stock on the grant date. After this grant, the director beneficially owns 21,743.456 shares of Ventas common stock, held directly.

Rhea-AI Summary

Ventas, Inc. director Roxanne M. Martino reported an acquisition of common stock units under the company’s Non-Employee Directors' Cash Compensation Deferral Plan. On 01/02/2026, she received 662.744 common stock units in lieu of director fees, at a reference price of $77.33 per share, based on the issuer’s closing stock price on the grant date. These units are payable solely in common stock and remain subject to the terms of her deferral election and the Plan. Following this grant, she beneficially owned 63,079.839 shares of Ventas common stock in direct ownership.

Rhea-AI Summary

Ventas, Inc. director reports stock units from deferred fees

A Ventas, Inc. director reported receiving 420.277 units of common stock on 01/02/2026, shown as an acquisition at a reference price of $77.33 per share. These units were granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan in lieu of cash director fees, based on the director's deferral election.

Following this transaction, the director beneficially owns 91,967.22 shares of Ventas common stock in direct form. The deferred units are payable solely in common stock and remain subject to the terms of the director's deferral election and the plan. The filing was signed on the director’s behalf by an attorney-in-fact under a power of attorney.

Rhea-AI Summary

Ventas, Inc. Chairman and CEO Debra A. Cafaro reported an insider transaction involving stock options and common shares of Ventas, Inc. on January 2, 2026. She exercised 10,322 stock options at an exercise price of $73.71 per share that were fully vested and scheduled to expire within the next eight months, and received the same number of common shares.

On the same date, she sold 10,322 common shares at a weighted average price of $77.2597 per share, as part of a Rule 10b5-1 trading plan that she entered into on March 28, 2024. In addition, 7,900 shares were withheld to cover taxes on the vesting of restricted stock units granted on March 19, 2025. After these transactions, she directly beneficially owned 1,137,795 shares of Ventas common stock and held 20,644 unexercised stock options.

Rhea-AI Summary

Ventas, Inc. executive reports stock sale and tax withholding

Ventas, Inc. EVP and CFO Robert F. Probst reported transactions in the company’s common stock dated 01/02/2026. He sold 29,930 shares in an open-market transaction under a Rule 10b5-1 trading plan entered into on February 19, 2025, at a weighted average price of $77.2532 per share, with individual trade prices ranging from $76.73 to $77.66. On the same date, 2,275 shares were withheld to cover taxes upon the vesting of restricted stock units granted on March 19, 2025 under the Ventas, Inc. 2022 Incentive Plan. Following these transactions, he beneficially owns 136,159 shares of Ventas common stock.

Rhea-AI Summary

Ventas, Inc. executive vice president and general counsel Carey S. Roberts reported a routine equity transaction involving company stock. On January 2, 2026, 1,609 shares of Ventas common stock were withheld by the company to cover taxes due on the vesting of restricted stock units that were granted on March 19, 2025 under the Ventas, Inc. 2022 Incentive Plan. The withholding price was $77.33 per share, which was the closing price of the stock on the vesting date. After this tax withholding, Roberts directly owns 115,041 shares of Ventas common stock.

Rhea-AI Summary

Ventas, Inc. executive James Justin Hutchens, EVP Senior Housing and CIO, reported an automatic share withholding related to equity compensation. On 01/02/2026, 2,043 shares of Ventas common stock were withheld to pay taxes upon the vesting of restricted stock units that were granted on March 19, 2025 under the Ventas, Inc. 2022 Incentive Plan.

The transaction was coded "F," indicating a tax-withholding event rather than a discretionary open-market trade. The withholding price was the $77.33 closing price per share on the vesting date. After this transaction, Hutchens beneficially owned 167,049 shares of Ventas common stock directly.

Rhea-AI Summary

Ventas, Inc. executive Peter J. Bulgarelli reported an automatic share withholding related to equity compensation. On 01/02/2026, the company withheld 1,676 shares of Ventas common stock to cover taxes due on the vesting of restricted stock units that were granted to him on March 19, 2025 under the Ventas, Inc. 2022 Incentive Plan. The withholding price was $77.33 per share, which reflects the closing price of Ventas common stock on the vesting date. After this tax withholding event, Bulgarelli beneficially owned 104,812 shares of Ventas common stock directly.

Rhea-AI Summary

Ventas, Inc. Chairman and CEO Debra A. Cafaro reported an option exercise and share sale involving the company’s common stock. On 12/01/2025, she exercised 10,322 stock options with an exercise price of $73.71 per share and acquired the same number of common shares. That same day, she sold 10,322 shares of common stock at a weighted average price of $80.5482 per share, in multiple transactions within a price range of $80.13 to $80.81. According to the disclosure, these actions were carried out under a Rule 10b5‑1 trading plan she entered into on March 28, 2024, and involved fully vested options scheduled to expire within the next nine months. After the transactions, Cafaro beneficially owned 1,145,695 shares of Ventas common stock directly and held 30,966 unexercised stock options.

Rhea-AI Summary

Ventas, Inc. (VTR) executive Peter J. Bulgarelli, who serves as EVP OM&R-Ventas and President & CEO of LHS, reported open-market sales of company stock on a Form 4. On November 18, 2025, he sold 2,771 shares of common stock at a weighted average price of $80.0074. On November 19, 2025, he sold an additional 2,229 shares at a weighted average price of $80.0827.

The filing states that these transactions were carried out under a Rule 10b5-1 trading plan that he entered into on February 20, 2025, which is a pre-arranged plan for selling shares. Following these sales, Bulgarelli directly beneficially owns 106,488 shares of Ventas common stock.

Rhea-AI Summary

Ventas, Inc. (VTR) Chair and CEO Debra A. Cafaro reported an option exercise and related share sale. On 11/17/2025, she exercised a stock option to buy 41,294 shares of common stock at an exercise price of $73.71 per share, then sold the same 41,294 shares at a weighted average price of $79.0075 per share. The filing states the transactions were made under a Rule 10b5-1 trading plan entered into on March 28, 2024 and involved options that were fully vested and scheduled to expire in the next 9 months. After these transactions, she directly beneficially owned 1,145,695 shares of common stock and held 41,288 unexercised stock options.

Rhea-AI Summary

Ventas (VTR) Form 4: EVP & CFO Robert F. Probst exercised stock options for 33,591 shares at $73.71 on 11/12/2025 and sold 33,591 shares at a weighted average price of $76.7719, pursuant to a Rule 10b5-1 trading plan entered on February 19, 2025.

The options were fully vested, scheduled to expire within the next nine months, and relate to an award first exercisable on 08/03/2016 with an expiration date of 08/03/2026. Following the transactions, Probst directly beneficially owns 168,364 shares. The sale occurred across multiple trades at prices ranging from $76.71 to $76.9376.

Rhea-AI Summary

Ventas, Inc. (VTR) disclosed a Form 4 for officer Peter J. Bulgarelli, who sold 40 shares of common stock on 11/07/2025 at a $75.7013 weighted average, with trades ranging from $75.26 to $76.14. The transaction was executed under a Rule 10b5-1 trading plan entered on February 20, 2025.

Following the sale, Bulgarelli beneficially owns 111,488 shares, held directly.

Rhea-AI Summary

Ventas, Inc. (VTR) reported insider stock sales by Executive Vice President (EVP OM&R-Ventas/Pres&CEO-LHS) Peter J. Bulgarelli. The transactions were open‑market sales coded “S” and executed under a Rule 10b5‑1 trading plan entered on February 20, 2025.

He sold 3,924 shares on 11/04/2025 at a weighted average price of $74.9966 (range $74.99–$75.11), 870 shares on 11/05/2025 at $75.2804 (range $74.99–$75.5623), and 166 shares on 11/06/2025 at $75.1535 (range $75.01–$75.39). Following these transactions, he beneficially owns 111,528 shares, held directly.

Rhea-AI Summary

Ventas (VTR) reported insider transactions by Chairman and CEO Debra A. Cafaro. On 11/04–11/06/2025, she exercised options at $63.24 for 11,452, 19,250, and 264 shares, then sold equal shares at weighted average prices of $75.0216, $75.2908, and $75.0489, pursuant to a Rule 10b5-1 plan entered on March 28, 2024. The options exercised were fully vested and scheduled to expire within the next 12 months. Following these trades, she directly owns 1,145,695 common shares and holds 82,582 unexercised options expiring on 11/02/2026.

Rhea-AI Summary

Ventas, Inc. (VTR) reported insider transactions by Chair and CEO Debra A. Cafaro. On 10/30/2025 and 11/03/2025, she exercised multiple fully vested stock options nearing expiration and sold the underlying shares, all pursuant to a Rule 10b5-1 trading plan entered on March 28, 2024.

Option exercises occurred at strike prices of $65.45, $73.71, $63.24, and $62.22. The corresponding share sales were executed at weighted average prices within disclosed ranges, including $74.00–$74.68 and $72.05–$74.71. Following these transactions, Cafaro beneficially owns 1,145,695 Ventas common shares directly and holds 113,548 unexercised options.

Rhea-AI Summary

Ventas (VTR) disclosed a Form 4 for Debra A. Cafaro, its Chairman and CEO. On 10/20/2025, she exercised stock options for 185,283 shares at $62.22 and 34,232 shares at $65.45, then sold the underlying shares at a weighted average price of $71.3227 under a Rule 10b5-1 plan entered into on March 28, 2024. The sales occurred in multiple transactions between $71.00 and $71.50. After these transactions, she directly beneficially owned 1,145,695 shares and held 451,450 unexercised options.

Rhea-AI Summary

Ventas, Inc. (VTR) director Maurice S. Smith reported automatic acquisitions of common stock units on 10/16/2025 from dividend equivalents tied to the company’s dividend paid the same day. The filing shows two credits: 59.484 units under the Non-Employee Directors' Cash Compensation Deferral Plan and 74.76 units under the Non-Employee Directors' Equity Award Deferral Program adopted under the 2022 Incentive Plan. The grant price reference was the $69.55 closing price per share as of the grant date. Following these transactions, beneficial ownership was 27,481.871 shares, held directly. The credited units are payable solely in common stock, per plan terms.

Rhea-AI Summary

Ventas, Inc. (VTR) reported an insider transaction by director Sumit Roy. On October 16, 2025, Roy acquired 49.89 common stock units via the Non-Employee Directors' Cash Compensation Deferral Plan and 74.76 common stock units via the Non-Employee Directors' Equity Award Deferral Program. These units were credited as dividend equivalents tied to the company’s dividend paid on that date and are payable solely in common stock. The reference price for the grants was $69.55, the closing price on the grant date.

Following the reported transactions, Roy beneficially owned 21,339.344 shares, held directly.

Rhea-AI Summary

Ventas, Inc. filed a Form 4 reporting an insider share acquisition. Director Joe V. Rodriguez, Jr. acquired 46.173 common stock units on 10/16/2025 as dividend equivalents under the Non-Employee Directors' Equity Award Deferral Program adopted pursuant to the 2022 Incentive Plan. These units are payable solely in common stock. The closing price per share as of the grant date was $69.55. After the transaction, he beneficially owned 7,764.461 shares, held directly.

Rhea-AI Summary

Ventas, Inc. (VTR) reported an insider transaction by a director. On October 16, 2025, the reporting person acquired 74.76 units of common stock credited as dividend equivalents under the Ventas Non-Employee Directors' Equity Award Deferral Program adopted pursuant to the 2022 Incentive Plan. The units are payable solely in common stock, using the $69.55 closing price per share as of the grant date. After this transaction, the reporting person beneficially owned 21,290.153 shares, held directly.

Rhea-AI Summary

Ventas (VTR): Director Roxanne M. Martino reported an acquisition of 201.433 shares of common stock on 10/16/2025, credited as dividend-equivalent units under the Ventas Non-Employee Directors' Cash Compensation Deferral Plan. The grant is payable solely in common stock and reflects the dividend paid on October 16, 2025. The price reference was the $69.55 closing price on the grant date. After this transaction, her beneficial ownership is 62,417.095 shares, held directly.

Rhea-AI Summary

Ventas (VTR) director Matthew J. Lustig reported routine acquisitions of common stock units on October 16, 2025 from dividend equivalents credited under director deferral programs. He received 250.738 units under the Non-Employee Directors' Cash Compensation Deferral Plan and 74.76 units under the Non-Employee Directors' Equity Award Deferral Program, each valued at the closing price of $69.55 per share as of the grant date. After these credits, he directly beneficially owned 91,546.943 shares.

Rhea-AI Summary

Ventas, Inc. (VTR): Director Michael J. Embler acquired 74.76 units payable in common stock on October 16, 2025 as dividend equivalents under the Non‑Employee Directors' Equity Award Deferral Program adopted pursuant to the 2022 Incentive Plan. The transaction was coded “A” (acquisition) in Table I. The filing notes a reference price of $69.55 per share as of the grant date. After this credit, Embler beneficially owned 14,520.153 shares, held directly.

Rhea-AI Summary

Ventas, Inc. (VTR) director Melody C. Barnes reported an acquisition of 74.76 shares of common stock on 10/16/2025. The shares reflect units credited as dividend equivalents under the Non-Employee Directors' Equity Award Deferral Program and are payable in common stock, consistent with her deferral election.

The filing cites a closing price of $69.55 per share on the grant date. After this transaction, Barnes directly owned 33,125.153 shares.

Rhea-AI Summary

Debra A. Cafaro, Chairman and CEO of Ventas, Inc. (VTR), reported transactions dated 10/01/2025 on Form 4 showing the exercise and sale of 10,322 shares. She exercised fully vested stock options with an exercise price of $65.45 that were exercisable from 05/04/2016 and scheduled to expire 05/04/2026. The shares were sold under a Rule 10b5-1 trading plan entered 03/28/2024 at a weighted average sale price of $70.237. After the transactions, her reported beneficial ownership was 1,145,695 shares and she holds 670,965 unexercised options.

Rhea-AI Summary

Peter J. Bulgarelli, an executive at Ventas, Inc. (VTR), reported two open-market sales executed under a Rule 10b5-1 trading plan entered on February 20, 2025. On 09/30/2025 he sold 2,040 shares at $69.99, reducing his stake to 119,042 shares. On 10/01/2025 he sold 2,554 shares at a weighted-average price of $70.2566, leaving him with 116,488 shares. The filing states the 10b5-1 plan covers these sales and discloses the reported price range of $69.9931 to $70.4706, with the reporting person offering to provide detailed per-trade quantities on request.